prices for GLP-1 medications are substantially higher than prices in peer nations, costing several times more in the United States than in countries such as Germany or the Netherlands
Consider External Review: If your appeal is denied, you may have the option to request an external review by an independent third party
Our Philosophy Personalized/precision medicine
By the first quarter of 2026, tirzepatide had become the most frequently prescribed agent at roughly 4,700 prescriptions per 100,000 patients, and semaglutide had grown to around 3,900 per 100,000
Given that sleep disruption is both a symptom of menopause and a driver of weight gain, this dual benefit is clinically meaningful
GLP-1 agonists are used to help manage type 2 diabetes and obesity as well as a few other conditions